Home › Funds › Citigroup Inc › IPHA
Citigroup Inc position in IPHA
INNATE PHARMA S A · Health Care
Latest position (Q4 2022)54 sh
Reported value held$201
Portfolio Weight0.00%
First reportedQ4 2021
Last changeHold
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2021 | 44 | $0 | New |
| Q1 2022 | 55 | $0 | Add |
| Q2 2022 | 55 | $0 | Hold |
| Q3 2022 | 54 | $0 | Reduce |
| Q4 2022 | 54 | $201 | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding IPHA
- Morgan Stanley 43.52K sh · $80.08K · Q2 2026
- Citadel Advisors 12.44K sh · $22.89K · Q2 2026
- UBS Group AG 1.36K sh · $2.51K · Q2 2026